$Histogenics(OCGN)$ Phase 3 results is now clinically trial sucessfully at 81%. Up 3 percent from the previous 78% annoncement. EUA Master file submitted in US. Lets hope good news will come soon for everyone. Cheers.[财迷] [财迷] [财迷]

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论7

  • 推荐
  • 最新